Honglian He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Honglian He has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chengfei Feng
Department of Anesthesiology, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Guangdong Provincial Clinical Research Center for Ocular Disease, Guangzhou, 510060, People’s Republic of China
1 shared publication - Jinfei Li
State Key Laboratory of Ophthalmology, Department of Anesthesiology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
1 shared publication - Jishuang Hong
Department of Anesthesiology, Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong, 510060, People’s Republic of China
1 shared publication Qianru Chen
1 shared publicationRui Zhang
1 shared publication- Wei Li
Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-14
Monocyte Transmigration Involves in Remifentanil Induced Mechanical Hyperalgesia in Animal Models and a Randomized Controlled Clinical Trial
Remifentanil−induced hyperalgesia (RIH) complicates postoperative pain management under total intravenous anesthesia. Although monocyte transmigration contributes to neuropathic pain, its role in RIH remains undefined. Here, we investigated monocyte dynamics in RIH through preclinical and clinical studies. In male mice, intraperitoneal remifentanil infusion (4 μg/kg/min, 1 h) induced sustained mechanical hyperalgesia (reduced paw withdrawal thresholds, PWTs) over 48 hours, paralleled by a transient decline in circulating monocytes (3 h post−infusion) and increased macrophage infiltration in paw tissues. Critically, monocyte depletion significantly attenuated RIH, implicating monocytes in its pathogenesis. Translating these findings, a randomized trial of 44 patients undergoing minor surgery under sevoflurane−remifentanil anesthesia (0.3 μg/kg/min) revealed that perioperative flurbiprofen axetil (1 mg/kg) attenuated remifentanil−induced mechanical hyperalgesia (peri−incisional and upper limb regions) at 2 h and 24 h postoperatively (p < 0.05). Mechanistically, flurbiprofen axetil prevented remifentanil−driven reductions in circulating monocytes and suppressed plasma CCL3/G−CSF elevations (p < 0.05), despite unchanged monocytic COX−2 expression. In vitro, remifentanil (1000 ng/mL) directly promoted peripheral blood mononuclear cell migration (p < 0.05) without affecting viability. Collectively, monocyte transmigration underlies RIH in both animal models and humans, while flurbiprofen axetil counteracts hyperalgesia by retaining monocytes in circulation and modulating chemokine signaling. These translational insights highlight monocyte−targeted strategies as a therapeutic avenue for RIH. In this study, we demonstrated that extravascular migration of circulating monocytes is involved in remifentanil-induced hyperalgesia. Flurbiprofen axetil attenuates remifentanil-induced hyperalgesia, possibly by suppressing monocyte extravasation.
- 1 April 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-14
Open AccessMonocyte Transmigration Involves in Remifentanil Induced Mechanical Hyperalgesia in Animal Models and a Randomized Controlled Clinical Trial
Remifentanil−induced hyperalgesia (RIH) complicates postoperative pain management under total intravenous anesthesia. Although monocyte transmigration contributes to neuropathic pain, its role in RIH remains undefined. Here, we investigated monocyte dynamics in RIH through preclinical and clinical studies. In male mice, intraperitoneal remifentanil infusion (4 μg/kg/min, 1 h) induced sustained mechanical hyperalgesia (reduced paw withdrawal thresholds, PWTs) over 48 hours, paralleled by a transient decline in circulating monocytes (3 h post−infusion) and increased macrophage infiltration in paw tissues. Critically, monocyte depletion significantly attenuated RIH, implicating monocytes in its pathogenesis. Translating these findings, a randomized trial of 44 patients undergoing minor surgery under sevoflurane−remifentanil anesthesia (0.3 μg/kg/min) revealed that perioperative flurbiprofen axetil (1 mg/kg) attenuated remifentanil−induced mechanical hyperalgesia (peri−incisional and upper limb regions) at 2 h and 24 h postoperatively (p < 0.05). Mechanistically, flurbiprofen axetil prevented remifentanil−driven reductions in circulating monocytes and suppressed plasma CCL3/G−CSF elevations (p < 0.05), despite unchanged monocytic COX−2 expression. In vitro, remifentanil (1000 ng/mL) directly promoted peripheral blood mononuclear cell migration (p < 0.05) without affecting viability. Collectively, monocyte transmigration underlies RIH in both animal models and humans, while flurbiprofen axetil counteracts hyperalgesia by retaining monocytes in circulation and modulating chemokine signaling. These translational insights highlight monocyte−targeted strategies as a therapeutic avenue for RIH. In this study, we demonstrated that extravascular migration of circulating monocytes is involved in remifentanil-induced hyperalgesia. Flurbiprofen axetil attenuates remifentanil-induced hyperalgesia, possibly by suppressing monocyte extravasation.
- Open Access
- 1 May 2024
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 18, 1865-1874
Effect of Preadministration of Nalmefene on Sufentanil-Induced Cough During Induction of General Anesthesia in Patients Undergoing Breast Surgery: A Double-Blind Randomized Controlled Trial
Purpose: This study was designed to investigate the effects of preadministration of nalmefene before general anesthesia induction on sufentanil-induced cough (SIC) in patients undergoing breast surgery. Patients and Methods: A total of 105 patients scheduled for elective breast surgery under general anesthesia were selected and randomly assigned into three groups: normal saline (Group C), low-dose nalmefene 0.1 μg·kg− 1 (Group LN), and high-dose nalmefene 0.25 μg·kg− 1 (Group HN). Sufentanil 0.5 μg·kg− 1 was injected intravenously within 2 s after 5 min of intervention. The count and severity of cough within 2 min after sufentanil injection, as well as the time to first cough, were recorded. In addition, we also collected intraoperative hemodynamic data, postoperative pain scores, the incidence of receiving rescue analgesics, and side effects up to 24 h after surgery. Results: Compared to Group C, the incidence of SIC was significantly lower in Group LN and HN (64.7% vs 30.3% and 14.7%, respectively; P < 0.001), but no significant difference was observed between the two groups (P=0.126). Compared to Group C, the risk factors decreased by 53.4% (95% confidence interval [CI] =0.181– 0.735, P=0.008) in Group LN and by 75.9% (95% CI=0.432– 0.898, P=0.001) in Group HN. Of the patients with SIC, less frequent SIC within 2 min after induction and a lower proportion of severe coughs were observed than Group C (P < 0.05), and no difference was detected between Group LN and HN. Additionally, the onset time to the first SIC did not differ significantly between the groups. Intraoperative hemodynamic data, postoperative pain scores, and side effects in the first 24 h did not differ among the groups. Conclusion: Preadministration of nalmefene prior to induction of general anesthesia effectively suppressed SIC in patients undergoing breast surgery, without affecting intraoperative hemodynamic fluctuation and postoperative pain intensity.
- 1 May 2024
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 18, 1865-1874
Open AccessEffect of Preadministration of Nalmefene on Sufentanil-Induced Cough During Induction of General Anesthesia in Patients Undergoing Breast Surgery: A Double-Blind Randomized Controlled Trial
Purpose: This study was designed to investigate the effects of preadministration of nalmefene before general anesthesia induction on sufentanil-induced cough (SIC) in patients undergoing breast surgery. Patients and Methods: A total of 105 patients scheduled for elective breast surgery under general anesthesia were selected and randomly assigned into three groups: normal saline (Group C), low-dose nalmefene 0.1 μg·kg− 1 (Group LN), and high-dose nalmefene 0.25 μg·kg− 1 (Group HN). Sufentanil 0.5 μg·kg− 1 was injected intravenously within 2 s after 5 min of intervention. The count and severity of cough within 2 min after sufentanil injection, as well as the time to first cough, were recorded. In addition, we also collected intraoperative hemodynamic data, postoperative pain scores, the incidence of receiving rescue analgesics, and side effects up to 24 h after surgery. Results: Compared to Group C, the incidence of SIC was significantly lower in Group LN and HN (64.7% vs 30.3% and 14.7%, respectively; P < 0.001), but no significant difference was observed between the two groups (P=0.126). Compared to Group C, the risk factors decreased by 53.4% (95% confidence interval [CI] =0.181– 0.735, P=0.008) in Group LN and by 75.9% (95% CI=0.432– 0.898, P=0.001) in Group HN. Of the patients with SIC, less frequent SIC within 2 min after induction and a lower proportion of severe coughs were observed than Group C (P < 0.05), and no difference was detected between Group LN and HN. Additionally, the onset time to the first SIC did not differ significantly between the groups. Intraoperative hemodynamic data, postoperative pain scores, and side effects in the first 24 h did not differ among the groups. Conclusion: Preadministration of nalmefene prior to induction of general anesthesia effectively suppressed SIC in patients undergoing breast surgery, without affecting intraoperative hemodynamic fluctuation and postoperative pain intensity.